Monday, May 11 Recap
Note – We believe this is the most up-to-date information available at this time, but it is subject to change as circumstances warrant. Also, all finalized resources can be found on the COVID-19 Resource Center page of Hall Render’s website.
OIG Updates FAQs on Administrative Enforcement Authorities on COVID-19 Arrangements
- OIG updated Frequently Asked Questions on “Application of OIG’s Administrative Enforcement Authorities to Arrangements Directly Connected to the (COVID-19) Public Health Emergency.”
Congressional Outlook
- House Democrats are still working on a draft stimulus bill that is expected to be released any day. The package is estimated to cost $3 trillion and will include additional funding for hospitals, as well as state and local governments, and more money for COVID-19 testing. It is also expected to include a number of long-standing Democratic policy priorities and is being drafted without input from House Republicans. Thus, it is being viewed more as a starting point for negotiations on another COVID-19 response bill that is not expected to come together for several months.
- The House and Senate remain in recess. The House could return to take up the Democrats’ stimulus bill at the end of this week or early next.
CMS Issues Letter for Nursing Home Facility Management and Staff
- CMS issued a letter to nursing home facility management and staff outlining nursing home specific regulations.
From the FDA
- The FDA added content to the question-and-answer appendix in its guidance “Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency.”
- The FDA issued the first Emergency Use Authorization for a COVID-19 antigen test, a new category of tests for use in the ongoing COVID-19 pandemic.
- The FDA updated the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency.
- The FDA issued an emergency use authorization for the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testing.
For more information, please contact:
- John Williams III at (202) 370-9585 or jwilliams@wp.hallrender.com;
- Andrew Coats at (202) 370-9587 or acoats@wp.hallrender.com;
- Abby Kaericher at (202) 780-2989 or akaericher@wp.hallrender.com; or
- Your regular Hall Render attorney.
Hall Render’s attorneys and professionals continue to maintain the most up-to-date information and resources at our COVID-19 Resource page, through our 24/7 COVID‑19 Hotline at (317) 429-3900 or by contacting your regular Hall Render attorney.
Hall Render blog posts and articles are intended for informational purposes only. For ethical reasons, Hall Render attorneys cannot—outside of an attorney-client relationship—answer specific questions that would be legal advice.
